nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—CYP1A2—type 2 diabetes mellitus	0.12	0.449	CbGaD
Naproxen—PTGS2—type 2 diabetes mellitus	0.0776	0.291	CbGaD
Naproxen—ALB—type 2 diabetes mellitus	0.0691	0.259	CbGaD
Naproxen—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.0246	0.0509	CbGbCtD
Naproxen—UGT2B7—Losartan—type 2 diabetes mellitus	0.0204	0.0422	CbGbCtD
Naproxen—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0191	0.0395	CbGbCtD
Naproxen—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0191	0.0395	CbGbCtD
Naproxen—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0176	0.0365	CbGbCtD
Naproxen—UGT1A1—Losartan—type 2 diabetes mellitus	0.0176	0.0364	CbGbCtD
Naproxen—ALB—Gliclazide—type 2 diabetes mellitus	0.0168	0.0347	CbGbCtD
Naproxen—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0167	0.0347	CbGbCtD
Naproxen—ALB—Repaglinide—type 2 diabetes mellitus	0.0158	0.0326	CbGbCtD
Naproxen—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0152	0.0315	CbGbCtD
Naproxen—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0149	0.0309	CbGbCtD
Naproxen—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0145	0.03	CbGbCtD
Naproxen—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.0141	0.0292	CbGbCtD
Naproxen—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0139	0.0287	CbGbCtD
Naproxen—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0132	0.0272	CbGbCtD
Naproxen—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0127	0.0263	CbGbCtD
Naproxen—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0122	0.0252	CbGbCtD
Naproxen—ALB—Valsartan—type 2 diabetes mellitus	0.0116	0.0241	CbGbCtD
Naproxen—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.011	0.0228	CbGbCtD
Naproxen—ALB—Nateglinide—type 2 diabetes mellitus	0.0108	0.0224	CbGbCtD
Naproxen—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0106	0.022	CbGbCtD
Naproxen—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0102	0.021	CbGbCtD
Naproxen—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00982	0.0203	CbGbCtD
Naproxen—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00972	0.0201	CbGbCtD
Naproxen—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00904	0.0187	CbGbCtD
Naproxen—SLC22A6—Glyburide—type 2 diabetes mellitus	0.00857	0.0177	CbGbCtD
Naproxen—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.008	0.0166	CbGbCtD
Naproxen—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00787	0.0163	CbGbCtD
Naproxen—SLC22A6—Losartan—type 2 diabetes mellitus	0.00784	0.0162	CbGbCtD
Naproxen—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00768	0.0159	CbGbCtD
Naproxen—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00768	0.0159	CbGbCtD
Naproxen—ALB—Glyburide—type 2 diabetes mellitus	0.0073	0.0151	CbGbCtD
Naproxen—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00709	0.0147	CbGbCtD
Naproxen—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00685	0.0142	CbGbCtD
Naproxen—ALB—Losartan—type 2 diabetes mellitus	0.00667	0.0138	CbGbCtD
Naproxen—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00626	0.013	CbGbCtD
Naproxen—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0062	0.0128	CbGbCtD
Naproxen—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00586	0.0121	CbGbCtD
Naproxen—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00582	0.0121	CbGbCtD
Naproxen—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00558	0.0116	CbGbCtD
Naproxen—CYP2C8—Losartan—type 2 diabetes mellitus	0.00516	0.0107	CbGbCtD
Naproxen—CYP1A2—Losartan—type 2 diabetes mellitus	0.00399	0.00827	CbGbCtD
Naproxen—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00393	0.00814	CbGbCtD
Naproxen—CYP2C9—Losartan—type 2 diabetes mellitus	0.0036	0.00745	CbGbCtD
Naproxen—Agomelatine—MTNR1A—type 2 diabetes mellitus	0.0012	0.282	CrCbGaD
Naproxen—PTGS2—leg—type 2 diabetes mellitus	0.000951	0.0736	CbGeAlD
Naproxen—PTGS2—hindlimb—type 2 diabetes mellitus	0.000849	0.0657	CbGeAlD
Naproxen—AKR1C3—islet of Langerhans—type 2 diabetes mellitus	0.00074	0.0572	CbGeAlD
Naproxen—Agomelatine—MTNR1B—type 2 diabetes mellitus	0.000629	0.148	CrCbGaD
Naproxen—AKR1C3—nephron tubule—type 2 diabetes mellitus	0.000596	0.0461	CbGeAlD
Naproxen—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000593	0.0459	CbGeAlD
Naproxen—UGT2B7—kidney—type 2 diabetes mellitus	0.000568	0.0439	CbGeAlD
Naproxen—PTGS1—artery—type 2 diabetes mellitus	0.000545	0.0421	CbGeAlD
Naproxen—PTGS2—artery—type 2 diabetes mellitus	0.000521	0.0403	CbGeAlD
Naproxen—AKR1C3—pancreas—type 2 diabetes mellitus	0.00052	0.0402	CbGeAlD
Naproxen—AKR1C3—cortex of kidney—type 2 diabetes mellitus	0.00051	0.0394	CbGeAlD
Naproxen—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000508	0.0393	CbGeAlD
Naproxen—UGT1A1—kidney—type 2 diabetes mellitus	0.000483	0.0373	CbGeAlD
Naproxen—AKR1C3—adipose tissue—type 2 diabetes mellitus	0.000472	0.0365	CbGeAlD
Naproxen—PTGS1—endothelium—type 2 diabetes mellitus	0.00046	0.0356	CbGeAlD
Naproxen—PTGS2—endothelium—type 2 diabetes mellitus	0.00044	0.034	CbGeAlD
Naproxen—Ibuprofen—THBD—type 2 diabetes mellitus	0.000371	0.0873	CrCbGaD
Naproxen—UGT2B7—liver—type 2 diabetes mellitus	0.000359	0.0278	CbGeAlD
Naproxen—AKR1C3—liver—type 2 diabetes mellitus	0.000331	0.0256	CbGeAlD
Naproxen—SLCO1A2—kidney—type 2 diabetes mellitus	0.000327	0.0253	CbGeAlD
Naproxen—UGT1A1—liver—type 2 diabetes mellitus	0.000305	0.0236	CbGeAlD
Naproxen—Ibuprofen—PLAT—type 2 diabetes mellitus	0.000254	0.0598	CrCbGaD
Naproxen—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.00025	0.0194	CbGeAlD
Naproxen—CYP2C8—kidney—type 2 diabetes mellitus	0.000228	0.0177	CbGeAlD
Naproxen—Indomethacin—PPARA—type 2 diabetes mellitus	0.000214	0.0505	CrCbGaD
Naproxen—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000207	0.016	CbGeAlD
Naproxen—SLCO1A2—liver—type 2 diabetes mellitus	0.000207	0.016	CbGeAlD
Naproxen—ALB—liver—type 2 diabetes mellitus	0.000205	0.0159	CbGeAlD
Naproxen—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000189	0.0146	CbGeAlD
Naproxen—PTGS1—kidney—type 2 diabetes mellitus	0.000185	0.0143	CbGeAlD
Naproxen—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000181	0.014	CbGeAlD
Naproxen—Nabumetone—CYP1A2—type 2 diabetes mellitus	0.000178	0.042	CrCbGaD
Naproxen—PTGS2—kidney—type 2 diabetes mellitus	0.000177	0.0137	CbGeAlD
Naproxen—PTGS2—pancreas—type 2 diabetes mellitus	0.000176	0.0136	CbGeAlD
Naproxen—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000167	0.0129	CbGeAlD
Naproxen—Agomelatine—HTR2C—type 2 diabetes mellitus	0.000161	0.0379	CrCbGaD
Naproxen—PTGS2—adipose tissue—type 2 diabetes mellitus	0.00016	0.0123	CbGeAlD
Naproxen—Ibuprofen—BCL2—type 2 diabetes mellitus	0.000146	0.0344	CrCbGaD
Naproxen—CYP2C8—liver—type 2 diabetes mellitus	0.000144	0.0112	CbGeAlD
Naproxen—CYP1A2—liver—type 2 diabetes mellitus	0.000135	0.0104	CbGeAlD
Naproxen—CYP2C9—liver—type 2 diabetes mellitus	0.000128	0.00992	CbGeAlD
Naproxen—Agomelatine—CYP1A2—type 2 diabetes mellitus	0.000121	0.0286	CrCbGaD
Naproxen—Nabumetone—PTGS2—type 2 diabetes mellitus	0.000116	0.0272	CrCbGaD
Naproxen—PTGS2—liver—type 2 diabetes mellitus	0.000112	0.00865	CbGeAlD
Naproxen—Carprofen—PTGS2—type 2 diabetes mellitus	0.00011	0.026	CrCbGaD
Naproxen—Indomethacin—PPARG—type 2 diabetes mellitus	0.000103	0.0242	CrCbGaD
Naproxen—Indomethacin—ABCC2—type 2 diabetes mellitus	0.0001	0.0236	CrCbGaD
Naproxen—Ibuprofen—PPARG—type 2 diabetes mellitus	8.09e-05	0.019	CrCbGaD
Naproxen—Suprofen—PTGS2—type 2 diabetes mellitus	6.82e-05	0.0161	CrCbGaD
Naproxen—Fenoprofen—PTGS2—type 2 diabetes mellitus	5.87e-05	0.0138	CrCbGaD
Naproxen—Fenoprofen—ALB—type 2 diabetes mellitus	5.23e-05	0.0123	CrCbGaD
Naproxen—Indomethacin—PTGS2—type 2 diabetes mellitus	4.33e-05	0.0102	CrCbGaD
Naproxen—Nervous system disorder—Metformin—type 2 diabetes mellitus	4e-05	0.000247	CcSEcCtD
Naproxen—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4e-05	0.000247	CcSEcCtD
Naproxen—Dyspnoea—Valsartan—type 2 diabetes mellitus	4e-05	0.000247	CcSEcCtD
Naproxen—Vertigo—Losartan—type 2 diabetes mellitus	3.99e-05	0.000246	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	3.99e-05	0.000246	CcSEcCtD
Naproxen—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.99e-05	0.000246	CcSEcCtD
Naproxen—Somnolence—Valsartan—type 2 diabetes mellitus	3.98e-05	0.000246	CcSEcCtD
Naproxen—Syncope—Losartan—type 2 diabetes mellitus	3.98e-05	0.000246	CcSEcCtD
Naproxen—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.98e-05	0.000245	CcSEcCtD
Naproxen—Leukopenia—Losartan—type 2 diabetes mellitus	3.98e-05	0.000245	CcSEcCtD
Naproxen—Discomfort—Irbesartan—type 2 diabetes mellitus	3.97e-05	0.000245	CcSEcCtD
Naproxen—Skin disorder—Metformin—type 2 diabetes mellitus	3.96e-05	0.000245	CcSEcCtD
Naproxen—Immune system disorder—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000244	CcSEcCtD
Naproxen—Hyperhidrosis—Metformin—type 2 diabetes mellitus	3.95e-05	0.000243	CcSEcCtD
Naproxen—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.95e-05	0.000243	CcSEcCtD
Naproxen—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000243	CcSEcCtD
Naproxen—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.93e-05	0.000242	CcSEcCtD
Naproxen—Dry mouth—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000242	CcSEcCtD
Naproxen—Palpitations—Losartan—type 2 diabetes mellitus	3.93e-05	0.000242	CcSEcCtD
Naproxen—Nausea—Glimepiride—type 2 diabetes mellitus	3.91e-05	0.000241	CcSEcCtD
Naproxen—Arrhythmia—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000241	CcSEcCtD
Naproxen—Loss of consciousness—Losartan—type 2 diabetes mellitus	3.9e-05	0.000241	CcSEcCtD
Naproxen—Nausea—Sitagliptin—type 2 diabetes mellitus	3.9e-05	0.000241	CcSEcCtD
Naproxen—Dyspepsia—Orlistat—type 2 diabetes mellitus	3.9e-05	0.000241	CcSEcCtD
Naproxen—Asthenia—Glyburide—type 2 diabetes mellitus	3.9e-05	0.000241	CcSEcCtD
Naproxen—Decreased appetite—Valsartan—type 2 diabetes mellitus	3.9e-05	0.00024	CcSEcCtD
Naproxen—Anorexia—Metformin—type 2 diabetes mellitus	3.89e-05	0.00024	CcSEcCtD
Naproxen—Cough—Losartan—type 2 diabetes mellitus	3.88e-05	0.000239	CcSEcCtD
Naproxen—Urticaria—Gliclazide—type 2 diabetes mellitus	3.88e-05	0.000239	CcSEcCtD
Naproxen—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	3.87e-05	0.000239	CcSEcCtD
Naproxen—Alopecia—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000239	CcSEcCtD
Naproxen—Fatigue—Valsartan—type 2 diabetes mellitus	3.86e-05	0.000238	CcSEcCtD
Naproxen—Indomethacin—ALB—type 2 diabetes mellitus	3.86e-05	0.0091	CrCbGaD
Naproxen—Abdominal pain—Gliclazide—type 2 diabetes mellitus	3.86e-05	0.000238	CcSEcCtD
Naproxen—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.86e-05	0.000238	CcSEcCtD
Naproxen—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000238	CcSEcCtD
Naproxen—Oedema—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000238	CcSEcCtD
Naproxen—Decreased appetite—Orlistat—type 2 diabetes mellitus	3.85e-05	0.000238	CcSEcCtD
Naproxen—Pruritus—Glyburide—type 2 diabetes mellitus	3.84e-05	0.000237	CcSEcCtD
Naproxen—Mental disorder—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000236	CcSEcCtD
Naproxen—Constipation—Valsartan—type 2 diabetes mellitus	3.83e-05	0.000236	CcSEcCtD
Naproxen—Flurbiprofen—PTGS2—type 2 diabetes mellitus	3.83e-05	0.00903	CrCbGaD
Naproxen—Infection—Irbesartan—type 2 diabetes mellitus	3.83e-05	0.000236	CcSEcCtD
Naproxen—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.82e-05	0.000236	CcSEcCtD
Naproxen—Fatigue—Orlistat—type 2 diabetes mellitus	3.82e-05	0.000236	CcSEcCtD
Naproxen—Hypotension—Metformin—type 2 diabetes mellitus	3.81e-05	0.000235	CcSEcCtD
Naproxen—Malnutrition—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000235	CcSEcCtD
Naproxen—Erythema—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000235	CcSEcCtD
Naproxen—Shock—Irbesartan—type 2 diabetes mellitus	3.79e-05	0.000234	CcSEcCtD
Naproxen—Pain—Orlistat—type 2 diabetes mellitus	3.79e-05	0.000234	CcSEcCtD
Naproxen—Myalgia—Losartan—type 2 diabetes mellitus	3.78e-05	0.000233	CcSEcCtD
Naproxen—Chest pain—Losartan—type 2 diabetes mellitus	3.78e-05	0.000233	CcSEcCtD
Naproxen—Arthralgia—Losartan—type 2 diabetes mellitus	3.78e-05	0.000233	CcSEcCtD
Naproxen—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.78e-05	0.000233	CcSEcCtD
Naproxen—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000233	CcSEcCtD
Naproxen—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.77e-05	0.000233	CcSEcCtD
Naproxen—Anxiety—Losartan—type 2 diabetes mellitus	3.77e-05	0.000233	CcSEcCtD
Naproxen—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000232	CcSEcCtD
Naproxen—Rash—Bromocriptine—type 2 diabetes mellitus	3.75e-05	0.000231	CcSEcCtD
Naproxen—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.74e-05	0.000231	CcSEcCtD
Naproxen—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.000231	CcSEcCtD
Naproxen—Tension—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000231	CcSEcCtD
Naproxen—Discomfort—Losartan—type 2 diabetes mellitus	3.74e-05	0.000231	CcSEcCtD
Naproxen—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.72e-05	0.00023	CcSEcCtD
Naproxen—Headache—Bromocriptine—type 2 diabetes mellitus	3.72e-05	0.00023	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.72e-05	0.000229	CcSEcCtD
Naproxen—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.72e-05	0.000229	CcSEcCtD
Naproxen—Nervousness—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000228	CcSEcCtD
Naproxen—Dry mouth—Losartan—type 2 diabetes mellitus	3.7e-05	0.000228	CcSEcCtD
Naproxen—Anorexia—Irbesartan—type 2 diabetes mellitus	3.67e-05	0.000227	CcSEcCtD
Naproxen—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.67e-05	0.000226	CcSEcCtD
Naproxen—Paraesthesia—Metformin—type 2 diabetes mellitus	3.67e-05	0.000226	CcSEcCtD
Naproxen—Muscle spasms—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000226	CcSEcCtD
Naproxen—Confusional state—Losartan—type 2 diabetes mellitus	3.66e-05	0.000226	CcSEcCtD
Naproxen—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.65e-05	0.000225	CcSEcCtD
Naproxen—Dyspnoea—Metformin—type 2 diabetes mellitus	3.64e-05	0.000225	CcSEcCtD
Naproxen—Somnolence—Metformin—type 2 diabetes mellitus	3.63e-05	0.000224	CcSEcCtD
Naproxen—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3.62e-05	0.000224	CcSEcCtD
Naproxen—Oedema—Losartan—type 2 diabetes mellitus	3.62e-05	0.000224	CcSEcCtD
Naproxen—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.62e-05	0.000223	CcSEcCtD
Naproxen—Infection—Losartan—type 2 diabetes mellitus	3.6e-05	0.000222	CcSEcCtD
Naproxen—Hypotension—Irbesartan—type 2 diabetes mellitus	3.6e-05	0.000222	CcSEcCtD
Naproxen—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.59e-05	0.000222	CcSEcCtD
Naproxen—Dyspepsia—Metformin—type 2 diabetes mellitus	3.59e-05	0.000222	CcSEcCtD
Naproxen—Tremor—Ramipril—type 2 diabetes mellitus	3.57e-05	0.00022	CcSEcCtD
Naproxen—Shock—Losartan—type 2 diabetes mellitus	3.57e-05	0.00022	CcSEcCtD
Naproxen—Urticaria—Valsartan—type 2 diabetes mellitus	3.56e-05	0.00022	CcSEcCtD
Naproxen—Nervous system disorder—Losartan—type 2 diabetes mellitus	3.55e-05	0.000219	CcSEcCtD
Naproxen—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.55e-05	0.000219	CcSEcCtD
Naproxen—Decreased appetite—Metformin—type 2 diabetes mellitus	3.55e-05	0.000219	CcSEcCtD
Naproxen—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.54e-05	0.000219	CcSEcCtD
Naproxen—Tachycardia—Losartan—type 2 diabetes mellitus	3.54e-05	0.000218	CcSEcCtD
Naproxen—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000218	CcSEcCtD
Naproxen—Nausea—Bromocriptine—type 2 diabetes mellitus	3.53e-05	0.000218	CcSEcCtD
Naproxen—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.52e-05	0.000217	CcSEcCtD
Naproxen—Fatigue—Metformin—type 2 diabetes mellitus	3.52e-05	0.000217	CcSEcCtD
Naproxen—Urticaria—Orlistat—type 2 diabetes mellitus	3.52e-05	0.000217	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.51e-05	0.000217	CcSEcCtD
Naproxen—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.5e-05	0.000216	CcSEcCtD
Naproxen—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.5e-05	0.000216	CcSEcCtD
Naproxen—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.5e-05	0.000216	CcSEcCtD
Naproxen—Asthenia—Gliclazide—type 2 diabetes mellitus	3.5e-05	0.000216	CcSEcCtD
Naproxen—Constipation—Metformin—type 2 diabetes mellitus	3.49e-05	0.000215	CcSEcCtD
Naproxen—Angioedema—Ramipril—type 2 diabetes mellitus	3.48e-05	0.000215	CcSEcCtD
Naproxen—Ketoprofen—PTGS2—type 2 diabetes mellitus	3.47e-05	0.00817	CrCbGaD
Naproxen—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.46e-05	0.000213	CcSEcCtD
Naproxen—Anorexia—Losartan—type 2 diabetes mellitus	3.46e-05	0.000213	CcSEcCtD
Naproxen—Vomiting—Glyburide—type 2 diabetes mellitus	3.45e-05	0.000213	CcSEcCtD
Naproxen—Pruritus—Gliclazide—type 2 diabetes mellitus	3.45e-05	0.000213	CcSEcCtD
Naproxen—Malaise—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000212	CcSEcCtD
Naproxen—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.000212	CcSEcCtD
Naproxen—Rash—Glyburide—type 2 diabetes mellitus	3.43e-05	0.000211	CcSEcCtD
Naproxen—Somnolence—Irbesartan—type 2 diabetes mellitus	3.42e-05	0.000211	CcSEcCtD
Naproxen—Dermatitis—Glyburide—type 2 diabetes mellitus	3.42e-05	0.000211	CcSEcCtD
Naproxen—Vertigo—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000211	CcSEcCtD
Naproxen—Syncope—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000211	CcSEcCtD
Naproxen—Flurbiprofen—ALB—type 2 diabetes mellitus	3.41e-05	0.00804	CrCbGaD
Naproxen—Ibuprofen—PTGS2—type 2 diabetes mellitus	3.41e-05	0.00804	CrCbGaD
Naproxen—Leukopenia—Ramipril—type 2 diabetes mellitus	3.41e-05	0.00021	CcSEcCtD
Naproxen—Headache—Glyburide—type 2 diabetes mellitus	3.4e-05	0.00021	CcSEcCtD
Naproxen—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.000209	CcSEcCtD
Naproxen—Hypotension—Losartan—type 2 diabetes mellitus	3.39e-05	0.000209	CcSEcCtD
Naproxen—Palpitations—Ramipril—type 2 diabetes mellitus	3.37e-05	0.000208	CcSEcCtD
Naproxen—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.36e-05	0.000208	CcSEcCtD
Naproxen—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.35e-05	0.000207	CcSEcCtD
Naproxen—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000207	CcSEcCtD
Naproxen—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.34e-05	0.000206	CcSEcCtD
Naproxen—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.34e-05	0.000206	CcSEcCtD
Naproxen—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.33e-05	0.000205	CcSEcCtD
Naproxen—Cough—Ramipril—type 2 diabetes mellitus	3.32e-05	0.000205	CcSEcCtD
Naproxen—Fatigue—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000205	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.3e-05	0.000204	CcSEcCtD
Naproxen—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.3e-05	0.000204	CcSEcCtD
Naproxen—Convulsion—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000204	CcSEcCtD
Naproxen—Constipation—Irbesartan—type 2 diabetes mellitus	3.29e-05	0.000203	CcSEcCtD
Naproxen—Pain—Irbesartan—type 2 diabetes mellitus	3.29e-05	0.000203	CcSEcCtD
Naproxen—Insomnia—Losartan—type 2 diabetes mellitus	3.28e-05	0.000202	CcSEcCtD
Naproxen—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.26e-05	0.000201	CcSEcCtD
Naproxen—Paraesthesia—Losartan—type 2 diabetes mellitus	3.25e-05	0.000201	CcSEcCtD
Naproxen—Urticaria—Metformin—type 2 diabetes mellitus	3.24e-05	0.0002	CcSEcCtD
Naproxen—Chest pain—Ramipril—type 2 diabetes mellitus	3.24e-05	0.0002	CcSEcCtD
Naproxen—Arthralgia—Ramipril—type 2 diabetes mellitus	3.24e-05	0.0002	CcSEcCtD
Naproxen—Myalgia—Ramipril—type 2 diabetes mellitus	3.24e-05	0.0002	CcSEcCtD
Naproxen—Dyspnoea—Losartan—type 2 diabetes mellitus	3.23e-05	0.000199	CcSEcCtD
Naproxen—Anxiety—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000199	CcSEcCtD
Naproxen—Nausea—Glyburide—type 2 diabetes mellitus	3.23e-05	0.000199	CcSEcCtD
Naproxen—Abdominal pain—Metformin—type 2 diabetes mellitus	3.23e-05	0.000199	CcSEcCtD
Naproxen—Dizziness—Gliclazide—type 2 diabetes mellitus	3.23e-05	0.000199	CcSEcCtD
Naproxen—Somnolence—Losartan—type 2 diabetes mellitus	3.22e-05	0.000199	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000199	CcSEcCtD
Naproxen—Asthenia—Valsartan—type 2 diabetes mellitus	3.22e-05	0.000198	CcSEcCtD
Naproxen—Discomfort—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000198	CcSEcCtD
Naproxen—Dyspepsia—Losartan—type 2 diabetes mellitus	3.19e-05	0.000197	CcSEcCtD
Naproxen—Asthenia—Orlistat—type 2 diabetes mellitus	3.18e-05	0.000196	CcSEcCtD
Naproxen—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.17e-05	0.000196	CcSEcCtD
Naproxen—Pruritus—Valsartan—type 2 diabetes mellitus	3.17e-05	0.000196	CcSEcCtD
Naproxen—Dry mouth—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000196	CcSEcCtD
Naproxen—Decreased appetite—Losartan—type 2 diabetes mellitus	3.15e-05	0.000194	CcSEcCtD
Naproxen—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.15e-05	0.000194	CcSEcCtD
Naproxen—Confusional state—Ramipril—type 2 diabetes mellitus	3.13e-05	0.000193	CcSEcCtD
Naproxen—Pruritus—Orlistat—type 2 diabetes mellitus	3.13e-05	0.000193	CcSEcCtD
Naproxen—Fatigue—Losartan—type 2 diabetes mellitus	3.13e-05	0.000193	CcSEcCtD
Naproxen—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000192	CcSEcCtD
Naproxen—Oedema—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000192	CcSEcCtD
Naproxen—Vomiting—Gliclazide—type 2 diabetes mellitus	3.1e-05	0.000191	CcSEcCtD
Naproxen—Constipation—Losartan—type 2 diabetes mellitus	3.1e-05	0.000191	CcSEcCtD
Naproxen—Pain—Losartan—type 2 diabetes mellitus	3.1e-05	0.000191	CcSEcCtD
Naproxen—Ketoprofen—ALB—type 2 diabetes mellitus	3.09e-05	0.00728	CrCbGaD
Naproxen—Rash—Gliclazide—type 2 diabetes mellitus	3.08e-05	0.00019	CcSEcCtD
Naproxen—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.07e-05	0.00019	CcSEcCtD
Naproxen—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.07e-05	0.000189	CcSEcCtD
Naproxen—Urticaria—Irbesartan—type 2 diabetes mellitus	3.06e-05	0.000189	CcSEcCtD
Naproxen—Shock—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000189	CcSEcCtD
Naproxen—Headache—Gliclazide—type 2 diabetes mellitus	3.06e-05	0.000189	CcSEcCtD
Naproxen—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000188	CcSEcCtD
Naproxen—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.04e-05	0.000188	CcSEcCtD
Naproxen—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.04e-05	0.000188	CcSEcCtD
Naproxen—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000188	CcSEcCtD
Naproxen—Ibuprofen—ALB—type 2 diabetes mellitus	3.04e-05	0.00716	CrCbGaD
Naproxen—Tachycardia—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000187	CcSEcCtD
Naproxen—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.03e-05	0.000187	CcSEcCtD
Naproxen—Skin disorder—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000186	CcSEcCtD
Naproxen—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3e-05	0.000185	CcSEcCtD
Naproxen—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.99e-05	0.000184	CcSEcCtD
Naproxen—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.96e-05	0.000183	CcSEcCtD
Naproxen—Dizziness—Valsartan—type 2 diabetes mellitus	2.96e-05	0.000183	CcSEcCtD
Naproxen—Anorexia—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000183	CcSEcCtD
Naproxen—Dizziness—Orlistat—type 2 diabetes mellitus	2.93e-05	0.000181	CcSEcCtD
Naproxen—Asthenia—Metformin—type 2 diabetes mellitus	2.93e-05	0.000181	CcSEcCtD
Naproxen—Hypotension—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000179	CcSEcCtD
Naproxen—Nausea—Gliclazide—type 2 diabetes mellitus	2.9e-05	0.000179	CcSEcCtD
Naproxen—Pruritus—Metformin—type 2 diabetes mellitus	2.89e-05	0.000178	CcSEcCtD
Naproxen—Urticaria—Losartan—type 2 diabetes mellitus	2.88e-05	0.000178	CcSEcCtD
Naproxen—Abdominal pain—Losartan—type 2 diabetes mellitus	2.87e-05	0.000177	CcSEcCtD
Naproxen—Body temperature increased—Losartan—type 2 diabetes mellitus	2.87e-05	0.000177	CcSEcCtD
Naproxen—Vomiting—Valsartan—type 2 diabetes mellitus	2.85e-05	0.000176	CcSEcCtD
Naproxen—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.84e-05	0.000175	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000175	CcSEcCtD
Naproxen—Rash—Valsartan—type 2 diabetes mellitus	2.83e-05	0.000174	CcSEcCtD
Naproxen—Dermatitis—Valsartan—type 2 diabetes mellitus	2.82e-05	0.000174	CcSEcCtD
Naproxen—Vomiting—Orlistat—type 2 diabetes mellitus	2.82e-05	0.000174	CcSEcCtD
Naproxen—Insomnia—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000173	CcSEcCtD
Naproxen—Headache—Valsartan—type 2 diabetes mellitus	2.81e-05	0.000173	CcSEcCtD
Naproxen—Diarrhoea—Metformin—type 2 diabetes mellitus	2.79e-05	0.000172	CcSEcCtD
Naproxen—Rash—Orlistat—type 2 diabetes mellitus	2.79e-05	0.000172	CcSEcCtD
Naproxen—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000172	CcSEcCtD
Naproxen—Dermatitis—Orlistat—type 2 diabetes mellitus	2.79e-05	0.000172	CcSEcCtD
Naproxen—Headache—Orlistat—type 2 diabetes mellitus	2.77e-05	0.000171	CcSEcCtD
Naproxen—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.77e-05	0.000171	CcSEcCtD
Naproxen—Asthenia—Irbesartan—type 2 diabetes mellitus	2.76e-05	0.000171	CcSEcCtD
Naproxen—Somnolence—Ramipril—type 2 diabetes mellitus	2.76e-05	0.00017	CcSEcCtD
Naproxen—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000169	CcSEcCtD
Naproxen—Pruritus—Irbesartan—type 2 diabetes mellitus	2.73e-05	0.000168	CcSEcCtD
Naproxen—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.7e-05	0.000167	CcSEcCtD
Naproxen—Dizziness—Metformin—type 2 diabetes mellitus	2.7e-05	0.000167	CcSEcCtD
Naproxen—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000166	CcSEcCtD
Naproxen—Fatigue—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000165	CcSEcCtD
Naproxen—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.67e-05	0.000165	CcSEcCtD
Naproxen—Nausea—Valsartan—type 2 diabetes mellitus	2.66e-05	0.000164	CcSEcCtD
Naproxen—Constipation—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000164	CcSEcCtD
Naproxen—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.64e-05	0.000163	CcSEcCtD
Naproxen—Nausea—Orlistat—type 2 diabetes mellitus	2.63e-05	0.000162	CcSEcCtD
Naproxen—Asthenia—Losartan—type 2 diabetes mellitus	2.6e-05	0.00016	CcSEcCtD
Naproxen—Vomiting—Metformin—type 2 diabetes mellitus	2.6e-05	0.00016	CcSEcCtD
Naproxen—Rash—Metformin—type 2 diabetes mellitus	2.57e-05	0.000159	CcSEcCtD
Naproxen—Dermatitis—Metformin—type 2 diabetes mellitus	2.57e-05	0.000159	CcSEcCtD
Naproxen—Pruritus—Losartan—type 2 diabetes mellitus	2.56e-05	0.000158	CcSEcCtD
Naproxen—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.56e-05	0.000158	CcSEcCtD
Naproxen—Headache—Metformin—type 2 diabetes mellitus	2.56e-05	0.000158	CcSEcCtD
Naproxen—Dizziness—Irbesartan—type 2 diabetes mellitus	2.55e-05	0.000157	CcSEcCtD
Naproxen—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000157	CcSEcCtD
Naproxen—Diarrhoea—Losartan—type 2 diabetes mellitus	2.48e-05	0.000153	CcSEcCtD
Naproxen—Urticaria—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000152	CcSEcCtD
Naproxen—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.46e-05	0.000152	CcSEcCtD
Naproxen—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.46e-05	0.000152	CcSEcCtD
Naproxen—Vomiting—Irbesartan—type 2 diabetes mellitus	2.45e-05	0.000151	CcSEcCtD
Naproxen—Rash—Irbesartan—type 2 diabetes mellitus	2.43e-05	0.00015	CcSEcCtD
Naproxen—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.43e-05	0.00015	CcSEcCtD
Naproxen—Nausea—Metformin—type 2 diabetes mellitus	2.42e-05	0.00015	CcSEcCtD
Naproxen—Headache—Irbesartan—type 2 diabetes mellitus	2.41e-05	0.000149	CcSEcCtD
Naproxen—Dizziness—Losartan—type 2 diabetes mellitus	2.4e-05	0.000148	CcSEcCtD
Naproxen—Vomiting—Losartan—type 2 diabetes mellitus	2.3e-05	0.000142	CcSEcCtD
Naproxen—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000141	CcSEcCtD
Naproxen—Nausea—Irbesartan—type 2 diabetes mellitus	2.29e-05	0.000141	CcSEcCtD
Naproxen—Rash—Losartan—type 2 diabetes mellitus	2.29e-05	0.000141	CcSEcCtD
Naproxen—Dermatitis—Losartan—type 2 diabetes mellitus	2.28e-05	0.000141	CcSEcCtD
Naproxen—Headache—Losartan—type 2 diabetes mellitus	2.27e-05	0.00014	CcSEcCtD
Naproxen—Asthenia—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000138	CcSEcCtD
Naproxen—Pruritus—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000136	CcSEcCtD
Naproxen—Nausea—Losartan—type 2 diabetes mellitus	2.15e-05	0.000133	CcSEcCtD
Naproxen—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.13e-05	0.000131	CcSEcCtD
Naproxen—Dizziness—Ramipril—type 2 diabetes mellitus	2.06e-05	0.000127	CcSEcCtD
Naproxen—Vomiting—Ramipril—type 2 diabetes mellitus	1.98e-05	0.000122	CcSEcCtD
Naproxen—Rash—Ramipril—type 2 diabetes mellitus	1.96e-05	0.000121	CcSEcCtD
Naproxen—Dermatitis—Ramipril—type 2 diabetes mellitus	1.96e-05	0.000121	CcSEcCtD
Naproxen—Headache—Ramipril—type 2 diabetes mellitus	1.95e-05	0.00012	CcSEcCtD
Naproxen—Nausea—Ramipril—type 2 diabetes mellitus	1.85e-05	0.000114	CcSEcCtD
Naproxen—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	4.04e-06	5.65e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	4.03e-06	5.64e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PPARG—type 2 diabetes mellitus	4.02e-06	5.62e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—SRC—type 2 diabetes mellitus	4e-06	5.6e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	4e-06	5.59e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	3.99e-06	5.58e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	3.98e-06	5.58e-05	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	3.98e-06	5.57e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	3.96e-06	5.55e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	3.96e-06	5.55e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	3.96e-06	5.54e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—INS—type 2 diabetes mellitus	3.94e-06	5.51e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—CCR5—type 2 diabetes mellitus	3.92e-06	5.48e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	3.91e-06	5.47e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.91e-06	5.47e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.9e-06	5.45e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	3.89e-06	5.45e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	3.89e-06	5.45e-05	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTGS2—type 2 diabetes mellitus	3.89e-06	5.44e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	3.89e-06	5.44e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	3.87e-06	5.42e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ALB—type 2 diabetes mellitus	3.87e-06	5.42e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.87e-06	5.42e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.86e-06	5.41e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	3.86e-06	5.41e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	3.86e-06	5.41e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	3.86e-06	5.41e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	3.85e-06	5.39e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	3.85e-06	5.39e-05	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—type 2 diabetes mellitus	3.85e-06	5.39e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	3.84e-06	5.37e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	3.84e-06	5.37e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	3.84e-06	5.37e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	3.83e-06	5.36e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	3.83e-06	5.36e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	3.83e-06	5.36e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.79e-06	5.31e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	3.77e-06	5.28e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	3.77e-06	5.28e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	3.76e-06	5.26e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	3.75e-06	5.25e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.75e-06	5.25e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.74e-06	5.23e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	3.73e-06	5.22e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	3.73e-06	5.22e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	3.73e-06	5.22e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	3.72e-06	5.2e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.71e-06	5.2e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	3.7e-06	5.18e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.7e-06	5.18e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	3.7e-06	5.18e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	3.69e-06	5.17e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	3.69e-06	5.17e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GCG—type 2 diabetes mellitus	3.67e-06	5.14e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	3.67e-06	5.14e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	3.65e-06	5.11e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IRS2—type 2 diabetes mellitus	3.64e-06	5.1e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	3.63e-06	5.08e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ALB—type 2 diabetes mellitus	3.61e-06	5.05e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.58e-06	5.01e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—CALM1—type 2 diabetes mellitus	3.58e-06	5e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOE—type 2 diabetes mellitus	3.56e-06	4.99e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	3.56e-06	4.98e-05	CbGpPWpGaD
Naproxen—AKR1C3—Disease—AKT1—type 2 diabetes mellitus	3.55e-06	4.97e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOA1—type 2 diabetes mellitus	3.52e-06	4.93e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.51e-06	4.91e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	3.48e-06	4.88e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.47e-06	4.86e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	3.47e-06	4.86e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.46e-06	4.85e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.46e-06	4.85e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.46e-06	4.85e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	3.46e-06	4.84e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.45e-06	4.83e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NOS3—type 2 diabetes mellitus	3.45e-06	4.83e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.4e-06	4.76e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	3.39e-06	4.74e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	3.39e-06	4.74e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.39e-06	4.74e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	3.38e-06	4.73e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.37e-06	4.72e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.34e-06	4.67e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.32e-06	4.65e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	3.32e-06	4.65e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS2—type 2 diabetes mellitus	3.32e-06	4.65e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.3e-06	4.62e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	3.3e-06	4.62e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	3.3e-06	4.62e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	3.3e-06	4.62e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SRC—type 2 diabetes mellitus	3.3e-06	4.62e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.3e-06	4.62e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.28e-06	4.59e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	3.27e-06	4.58e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.22e-06	4.51e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	3.21e-06	4.5e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—INS—type 2 diabetes mellitus	3.21e-06	4.49e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	3.2e-06	4.49e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.18e-06	4.46e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.18e-06	4.45e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	3.18e-06	4.45e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IRS1—type 2 diabetes mellitus	3.18e-06	4.45e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.17e-06	4.43e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	3.17e-06	4.43e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GNB3—type 2 diabetes mellitus	3.16e-06	4.43e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.16e-06	4.43e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.16e-06	4.42e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	3.15e-06	4.41e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	3.14e-06	4.4e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.13e-06	4.39e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.13e-06	4.39e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	3.12e-06	4.37e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CAT—type 2 diabetes mellitus	3.11e-06	4.35e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.06e-06	4.28e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	3.04e-06	4.26e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—INS—type 2 diabetes mellitus	3.04e-06	4.26e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.04e-06	4.25e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	3.03e-06	4.25e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOB—type 2 diabetes mellitus	3.02e-06	4.22e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3e-06	4.2e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3e-06	4.2e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	2.99e-06	4.19e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	2.98e-06	4.18e-05	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—AKT1—type 2 diabetes mellitus	2.97e-06	4.16e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.97e-06	4.16e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.96e-06	4.14e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.96e-06	4.14e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.96e-06	4.14e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	2.95e-06	4.13e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	2.95e-06	4.13e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	2.95e-06	4.13e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	2.94e-06	4.12e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—AKT2—type 2 diabetes mellitus	2.94e-06	4.12e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	2.93e-06	4.11e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.91e-06	4.07e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	2.9e-06	4.05e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.88e-06	4.03e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—LPL—type 2 diabetes mellitus	2.88e-06	4.03e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.84e-06	3.98e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	2.84e-06	3.97e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	2.83e-06	3.95e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	2.82e-06	3.95e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.82e-06	3.94e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	2.82e-06	3.94e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.82e-06	3.94e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GPX1—type 2 diabetes mellitus	2.81e-06	3.93e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	2.8e-06	3.91e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	2.75e-06	3.85e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CD36—type 2 diabetes mellitus	2.74e-06	3.83e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.72e-06	3.8e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.71e-06	3.79e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	2.7e-06	3.78e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.7e-06	3.77e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.68e-06	3.75e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	2.67e-06	3.74e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS3—type 2 diabetes mellitus	2.67e-06	3.74e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.61e-06	3.65e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.61e-06	3.65e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	2.6e-06	3.64e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.6e-06	3.64e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	2.59e-06	3.63e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.59e-06	3.62e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.59e-06	3.62e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.58e-06	3.61e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	2.58e-06	3.6e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.57e-06	3.59e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.57e-06	3.59e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.56e-06	3.58e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—INS—type 2 diabetes mellitus	2.55e-06	3.57e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARA—type 2 diabetes mellitus	2.54e-06	3.56e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.54e-06	3.56e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.49e-06	3.48e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.48e-06	3.47e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.47e-06	3.46e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—AGT—type 2 diabetes mellitus	2.46e-06	3.45e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.44e-06	3.41e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.43e-06	3.4e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CALM1—type 2 diabetes mellitus	2.42e-06	3.39e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOE—type 2 diabetes mellitus	2.41e-06	3.38e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.4e-06	3.36e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.4e-06	3.36e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOA1—type 2 diabetes mellitus	2.39e-06	3.34e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.36e-06	3.3e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	2.34e-06	3.27e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.31e-06	3.23e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.3e-06	3.22e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.24e-06	3.13e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	2.24e-06	3.13e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.24e-06	3.13e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.21e-06	3.1e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.21e-06	3.1e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.21e-06	3.1e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.2e-06	3.08e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.17e-06	3.04e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.12e-06	2.97e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.11e-06	2.96e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.11e-06	2.95e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.1e-06	2.94e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.08e-06	2.91e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.07e-06	2.9e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—INS—type 2 diabetes mellitus	2.06e-06	2.89e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.05e-06	2.87e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.05e-06	2.87e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.02e-06	2.82e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.01e-06	2.82e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.98e-06	2.78e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.98e-06	2.77e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—SRC—type 2 diabetes mellitus	1.97e-06	2.76e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.97e-06	2.76e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.97e-06	2.75e-05	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	1.95e-06	2.73e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.95e-06	2.73e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.91e-06	2.68e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.9e-06	2.66e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.89e-06	2.65e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.82e-06	2.55e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.82e-06	2.55e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.81e-06	2.54e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	1.81e-06	2.53e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—NOS3—type 2 diabetes mellitus	1.81e-06	2.53e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.78e-06	2.49e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	1.76e-06	2.47e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—EGFR—type 2 diabetes mellitus	1.73e-06	2.42e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.72e-06	2.41e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.72e-06	2.41e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.7e-06	2.38e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.69e-06	2.37e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.69e-06	2.36e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.69e-06	2.36e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.67e-06	2.34e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.66e-06	2.33e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.65e-06	2.31e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.59e-06	2.22e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.55e-06	2.17e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.48e-06	2.07e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.48e-06	2.07e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.47e-06	2.06e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.44e-06	2.02e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.35e-06	1.89e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—type 2 diabetes mellitus	1.33e-06	1.86e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.32e-06	1.85e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	1.29e-06	1.81e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.26e-06	1.77e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.26e-06	1.77e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—AKT1—type 2 diabetes mellitus	1.23e-06	1.72e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.16e-06	1.62e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-06	1.44e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	8.36e-07	1.17e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—AKT1—type 2 diabetes mellitus	8.31e-07	1.16e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	6.8e-07	9.52e-06	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.81e-07	8.14e-06	CbGpPWpGaD
